Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47 000 MW acid labile protein in CD4+T-cell recognition

Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification

(2013) G. Ott et al.   BLOOD

Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion

(2013) J. Tel et al.   JOURNAL OF IMMUNOLOGY

CD4+ T Cells Play a Critical Role in the Generation of Primary and Memory Antitumor Immune Responses Elicited by SA-4-1BBL and TAA-Based Vaccines in Mouse Tumor Models

(2013) Rajesh K. Sharma et al.   PLoS One

First crystal structure of an endo-inulinase, INU2, from Aspergillus ficuum: Discovery of an extra-pocket in the catalytic domain responsible for its endo-activity

(2012) Jenny Pouyez et al.   BIOCHIMIE

Burkitt lymphoma: the role of Epstein-Barr virus revisited

(2012) Sebastian Grömminger et al.   BRITISH JOURNAL OF HAEMATOLOGY

Epidemiology: clues to the pathogenesis of Burkitt lymphoma

(2012) Ian Magrath   BRITISH JOURNAL OF HAEMATOLOGY

Burkitt's lymphoma

(2012) Elizabeth M Molyneux et al.   LANCET

Practical recommendations for the management of children with Endemic Burkitt Lymphoma (BL) in a resource limited setting

(2012) Peter Hesseling et al.   PEDIATRIC BLOOD & CANCER

MYC and Aggressive B-cell Lymphomas

(2011) Graham W. Slack et al.   ADVANCES IN ANATOMIC PATHOLOGY

HLA Class II Defects in Burkitt Lymphoma: Bryostatin-1-Induced 17 kDa Protein Restores CD4+ T-Cell Recognition

(2011) Azim Hossain et al.   Clinical & Developmental Immunology

Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens

(2011) Maurizio Bruschi et al.   Journal of Proteomics

Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol

(2011) Faisal F. Y. Radwan et al.   LEUKEMIA & LYMPHOMA

HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide

(2010) Anne-Kathrin Anders et al.   NATURE IMMUNOLOGY

Burkitt Lymphoma: Pathogenesis and Immune Evasion

(2010) Jason M. God et al.   Journal of Oncology

Childhood Burkitt Lymphoma: Abdominal and Pelvic Imaging Findings

(2009) David M. Biko et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach

(2009) Cristiana Bellan et al.   HEMATOLOGICAL ONCOLOGY

High‐dose chemotherapy and immunotherapy in adult Burkitt lymphoma

(2008) Albert Oriol et al.   CANCER

Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma

(2008) Oliver G. Goldstein et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Anti- -enolase Antibodies in Patients with Inflammatory Bowel Disease

(2008) N. Vermeulen et al.   CLINICAL CHEMISTRY

HLA‐DM negatively regulates HLA‐DR4‐restricted collagen pathogenic peptide presentation and T cell recognition

(2008) Shereen Amria et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Defects in HLA class II antigen presentation in B-cell lymphomas

(2008) Shereen Amria et al.   LEUKEMIA & LYMPHOMA

Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia

(2008) Laimonas Griskevicius et al.   LEUKEMIA RESEARCH

Burkitt Lymphoma in Adults

(2008) A. S. Perkins et al.   Hematology-American Society of Hematology Education Program

Epstein-Barr virus and Burkitt lymphoma

(2007) G Brady et al.   POSTGRADUATE MEDICAL JOURNAL